The Alberta Psychiatric Association requires disclosure of the existence of ANY AND ALL financial interest(s) or other affiliation(s) a presenter has with commercial supporter(s) of these educational activities, and/or with manufacturer(s) of ANY AND ALL commercial product(s) and/or provider(s) of ANY AND ALL commercial services discussed in the scientific program. The existence of such relationships does not necessarily constitute a conflict of interest, but the prospective audience must be informed of the presenter’s affiliation with every commercial sponsor by way of an acknowledgement in program.
This policy is intended to openly identify any potential conflict(s) so that members of the audience in an educational activity are able to form their own opinions about the presentation. A reasonable test to guide decisions about what to disclose is whether any particular affiliation could cause embarrassment to the individual or institution involved or lead to questions about the presenter’s motives if such affiliation(s) were made known to the general public.
The following presenters have indicated a financial interest or other affiliation with a commercial supporter of the session and/or with the manufacturer(s) of a commercial product and/or provider of commercial service(s):
Speaker | Co-Author | Affiliation |
Nia Abdullayeva | N/A |
N/A |
Sean Andrea | Megan Puckering |
N/A |
David Attwood |
Served as a speaker and consultant for the following companies; AA pharma, HLS Therapeutics, Otsuka, Lundbeck, Abbvie, Boehringer |
|
Prajjita Bardoloi | N/A |
N/A |
Simon Baron-Cohen | N/A |
N/A |
Janet Caryk | Novjyot (Joti) Brar-Josan |
N/A |
Kaitlyn Chappell, Laura Stovel, and Diana Meakins | Melanie Marsh-Joyal, Allison Bihari, Karen Kroeker |
Allison Bihari - Co-Primary Investigator for a Digestive Health Strategic Clinical Network Grant, Alberta Health Services Kaitlyn Chappell - Co-Investigator: Mindfulness-Based Stress Reduction (MBSR) for Adults with Inflammatory Bowel Disease (MIND-IBD, UofA Study ID: Pro00108955) Karen Kroeker - Mentoring in IBD, Steering Committee Member Crohn’s and Colitis Canada PACE Steering Committee, Co-Lead Royal College Gastroenterology Specialty Committee, Vice Chair. Co-Primary Investigator for a Quality Improvement Grant, “Addressing the Needs of with Mental Health Issues and Inflammatory Bowel Disease”, Pfizer Canada Co-Primary Investigator for a Digestive Health Strategic Clinical Network Diana Meakins - Physician Member, Alberta Medical Association (AMA) Healthy Working Melanie Marsh-Joyal - Alberta Health Services (AHS) for AHS Zone Clinical Department Facility Chief (ZCDFC), Adult Psychiatry, Royal Alexandra Hospital (RAH), 2023-present. Payment from Alberta Health Services (AHS) for AHS Zone Clinical Department Facility Chief (ZCDFC), Adult Psychiatry, Royal Alexandra Hospital (RAH) Laura Stovel - Psychiatrist Member, Alberta Mental Health Review Panel, North Sector, 2020-present, Psychiatrist Member, Criminal Code Review Board, 2021-present |
Kaitlin Chivers-Wilson Thomas Stark |
Thomas Stark Erin Talbot Christina Volstad Evelyne Felber Charbonneau |
Kaitlyn Chivers - Practise Supports and Provincial Partnerships Accreditation Committee; Newly Institute Scientific Advisory Board. Research support from Veterans Affairs Canada and Calgary Health Trust. Speaker honoraria from Abbvie. Evelyne Felber Charbonneau - N/A Thomas Stark - HLS Therapeutics, Otsuka, EISIA - Fees for Educational Talks and receipt of honoraria Erin Talbot - Employee of Carwest Operational Stress Injury Clinic Christina Volstad - N/A |
Pratap R. Chokka & Toba Oluboka |
Pratap R. Chokka - Abbvie, Lundbeck, Janssen, Takeda, Otsuka Toba Oluboka - Janssen Canda, Otsuka Canada, Lundbeck Canada, VIATRIS, Eisai, Pfizer Pharmaceutical,HLS Therapeutics, Abbvie, Allergan, Otsuka-Lundbeck Alliance |
|
Janet de Groot & Elizabeth Wallace |
Janet de Groot - Alberta Cancer Foundation Grant 2020-20232. Cumming School of Medicine, OHMES-EDI grant 2023-20253. Carol May Yates Memorial Endowment Grant for Cancer Research 2023-2024 Elizabeth Wallace - N/A |
|
Shaista Goel | Maryana Kravtsenyuk |
N/A |
Payman Hajiazim | N/A |
Lectures before for the physicians while supported by Novartis, Abbvie, Eisai, Paladin Abbvie, Eisai, Flamel, Idorsia, Novartis, Paladin, Sunovion, |
Tyler Halverson | Joao Morgadinho, Kannayiram Alagiakrishnan |
Tyler Halverson - N/A Joao Morgadinho - Alberta Health Services, University of Alberta Kannayiram Alagiakrishnan - Alberta Health Services, University of Alberta Hospital |
Steve Hyman | N/A |
Director, Voyager Therapeutics Scientific Advisory Board J&J |
Maryana Kravtsenyuk | Gary A. Chaimowitz |
N/A |
John Krystal | N/A |
Stock from Biohaven Pharmaceuticals and Spring Care, Inc. Stock Options from Biohaven Pharmaceuticals Medical SciencesClearmind Medicine, Inc. EpiVario, Inc.Neumora Therapeutics, Inc. Tempero Bio, Inc.Terran Biosciences, Inc.Tetricus, Inc. Editorial Board - Editor - Biological Psychiatry Freedom Biosciences, Inc. – Science Advisory Board Patents include:
Funded grants or clinical trials include: NON Federal Research Support AstraZeneca Pharmaceuticals provides the drug, Saracatinib, for research related to NIAAA grant “Center for Translational Neuroscience of Alcoholism [CTNA-4] Novartis provides the drug, Mavoglurant, for research related to NIAAA grant “Center for Translational Neuroscience of Alcoholism [CTNA-5] Cerevel provides the drug PF-06412562 for A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia (5 U01 MH121766-03) Membership on advisory boards or speakers' bureaus include AE Research Foundation Advisory BoardBiogen, Idec, MABiohaven PharmaceuticalsBioXcel Therapeutics, Inc. (Clinical Advisory Board)Cerevel Therapeutics, LLCDelix Therapeutics, Inc.Eisai, Inc.EpiVario, Inc.Freedom Biosciences, Inc.Jazz Pharmaceuticals, Inc.Neumora Therapeutics, Inc. Neurocrine Biosciences, Inc.Novartis Pharmaceuticals CorporationPerception Neuroscience, Inc. Praxis Precision Medicines, Inc.PsychoGenics, Inc.Takeda IndustriesTempero Bio, Inc.Terran Biosciences, Inc.Tetricus, Inc. Financial payments include Consultant for:Aptinyx, Inc.Biogen, Idec, MABionomics, Limited (Australia)BioXcel TherapeuticsBoehringer Ingelheim InternationalCerevel Therapeutics, LLCClearmind Medicine, Inc.Cybin IRL (Ireland Limited Company)Enveric BiosciencesEpiodyne, Inc. EpiVario, Inc.Evidera, Inc.Janssen Research & DevelopmentJazz Pharmaceuticals, Inc.Leal Therapeutics, Inc.Otsuka America Pharmaceutical, Inc.Perception Neuroscience, Inc. Praxis Precision Medicines, Inc.Spring Care, Inc.Sunovion Pharmaceuticals, Inc.Tetricus, Inc. |
Charlene Lyndon |
Maryana Kravtsenyuk |
Charlene Lyndon - Calgary Area Medical Staff Society, President; Edmonton Zone Medical Association, Co-Chair Women’s Health Advocacy Committee, CPSA Indigenous Advisory Circle, Stipend from CAMSS, Hourly AMA rate from EZMSA, Hourly rate from CPSA Maryana Kravtsenyuk - N/A |
Usama Malik |
Jennifer Swainson, Matthew Reeson, Ian Stefanuk, Mary Cummins, Sudhakar Sivapalan |
Usama Malik - N/A |
Alexandra McPherson | N/A |
CAMAP (Board Member), Honoraria from Health Canada |
Hassan Nawab | Morgan Glass, Thomas Raedler |
Morgan Glass - University of Toronto Hassan Nawab - N/A Thomas Raedler - Abbvie / Allergan, AMHSP of the University of Calgary, Boehringer / Ingelheim, HLS, Newron, Otsuka, Sunovion, SyneuRx International, TEVA |
Rachael Nicholls | Davide Martino, Tamara Pringsheim, Natalia Szejko |
Davide Martino- Merz Pharmaceuticals - Abbvie Rachael Nicholls - N/A Tamara Pringsheim - CIHR Natalia Szejko - American Academy of Neurology, American Brain Foundation, Biogen, Polish Ministry of Health, Tourette Association of America |
Abhinav Pillai | Tan Li, Sharon Parappally-Joseph, Martin Vetter |
Tan Li - N/A Sharon Parappally-Joseph - N/A Abhinav Pillai - OpenAI Research Grant Martin Vetter - Elvium advisory board, Elvium speaker fee |
Thomas Joseph Raedler | N/A |
Abbvie / Allergan, AMHSP of the University of Calgary, Boehringer / Ingelheim, HLS, Newron, Otsuka, Sunovion, SyneuRx International, TEVA |
Roger Rampling | N/A |
N/A |
Hasina Samji | N/A |
BC Centre for Disease Control, CIHR, Simon Fraser University and SSHRC. |
Dallas Seitz | N/A |
Canadian Institutes of Health Research, University Health Foundation - Alberta Roche Collaboration in Health, Alzheimer Association, Calgary Health Foundation, Public Health Agency of Canada Stipend from Alberta Health Services for Scientific Director of PAMH. |
Rory Sellmer and Monique Jericho | N/A |
Monique Jericho - Silver Linings Foundation, Lionheart Foundation, Clinical consultation support with accessing grants Rory Sellmer - Ad boards for Otsuka, Abbvie, and HLS therapeutics. Speaker fees for Abbvie. |
Norma Shipley | N/A |
Alberta Medical Association |
Thomas Stark | Martin Vetter |
Thomas Stark - HLS Therapeutics, Otsuka, EISIA - Fees for Educational Talks and receipt of honoraria Martin Vetter - Elvium advisory board, Elvium speaker fee |
John Strang | N/A |
Action on Addiction, Addictions CAG (Clinical Academic Group), Clouds (Action on Addiction), DrugFAM, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), FDA (US Food and Drug Administration), Institute of Psychiatry, Psychology and Neuroscience, KCA (Kent Council on Addictions), Kings College London, King’s Health Partners Academic Health Sciences Centre, Lifeline (Manchester), NIDA (US National Institute on Drug Abuse), Phoenix House, Scottish Drug Forum (SDF), Scottish Families affected by Alcohol and Drigs (SFAD), South London & Maudsley (SLaM) NHS Foundation Trust, UK Drug Policy Commission (UKDPC), United Nations Office on Drugs and Crime (UNODC) and World Health Organization (WHO).4 Grant support/honoraria/consultancy payments from Accord/Molenti, Camurus, Department of Health, EMCDDA (European Monitoring Centre for Drugs and Drug Addiction), Home Office, NICE (National Institute for Health and Clinical Excellence), NIHR (National Institute on Health Research), NTA (National Treatment Agency), MRC (Medical Research Council), MundiPharma, PHE (Public Health England), Pilgrim Trust, SME Pneumowave, SHIP/OLS/SBRI, Societyy for the Study of Addcition (SSA) and Q2i/CMI. |
Gustavo Turecki | N/A | N/A |
Bohan Yang | Marnie MacKay, Serdar M. Dursun, Glen B. Baker |
Glen B. Baker - Member of SAB, but gave advice on basic science studies on MAO inhibitors that has no relationship to Bohan’s presentation. I stepped down from the SAB in April, 2023. Received $1,000 USD per month, which stopped after April, 2023. Serdar M. Dursun - N/A Marnie MacKay - N/A Bohan Yang - N/A |
Verna Yiu | N/A | N/A |